Thomas Dix to Neurotensin
This is a "connection" page, showing publications Thomas Dix has written about Neurotensin.
Connection Strength
1.917
-
Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic. J Med Chem. 2010 Jun 24; 53(12):4623-32.
Score: 0.341
-
Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. J Med Chem. 2009 Apr 09; 52(7):1803-13.
Score: 0.313
-
Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology. 2005 Dec; 49(8):1149-59.
Score: 0.243
-
In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Neuropharmacology. 2005 Mar; 48(3):417-25.
Score: 0.236
-
Cellular uptake of a radiolabelled analogue of neurotensin in the Caco-2 cell model. J Pharm Pharmacol. 2005 Mar; 57(3):327-33.
Score: 0.236
-
In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues. J Med Chem. 2003 Sep 11; 46(19):4141-8.
Score: 0.213
-
Monitoring neurotensin[8-13] degradation in human and rat serum utilizing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem. 2002 Sep 01; 308(1):34-41.
Score: 0.198
-
A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J. 2012 Jul; 26(7):2799-810.
Score: 0.096
-
Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice. Exp Neurol. 2020 03; 325:113133.
Score: 0.041